Luis Antonio Aguirre-Zorzano1, Ruth Estefanía-Fresco2, Olatz Telletxea3, Manuel Bravo4. 1. Dpto. De Estomatología (Postgrado de Periodoncia), Facultad de Medicina y Odontología UPV/EHU, Leioa, Spain. 2. Estomatología II (Postgrado de Periodoncia), Universidad del País Vasco, Leioa, Spain. 3. Estomatología II (Postgrado de Periodoncia), Facultad de Medicina y Odontología UPV/EHU, Leioa, Spain. 4. Preventive and Community Dentistry, School of Dentistry, University of Granada, Granada, Spain.
Abstract
OBJECTIVES: To describe the status of implants in periodontally compromised patients who regularly receive supportive periodontal therapy (SPT) and to determine the factors associated to peri-implant inflammatory disease in those patients. MATERIAL AND METHODS: Clinical and radiographic data of implants in periodontal patients who, after being treated and included in a SPT programme, wore implant prostheses for at least 6 months were recorded. The implants were classified according to the criteria of the 6th European Workshop on Periodontology in health, mucositis and peri-implantitis. Logistic regression analysis was performed to analyse the individual and adjusted effects of each study variable on mucositis or peri-implantitis, using SUDAAN to account for clustering (multiple implants within the patient). RESULTS: A total of 786 implants were placed in 239 patients. At patient level, 60.3%, 24.7% and 15.1% were classified as healthy, mucositis and peri-implantitis patients, respectively. At implant level, the respective percentages were 77.4%, 12.8% and 9.8%. For mucositis, at implant level, the adjusted ORs indicate a significant association with plaque index (P = 0.050), type of periodontitis (P = 0.030) and location (P = 0.045). For peri-implantitis, the adjusted ORs indicate a significant association with plaque index (P < 0.001) and location (P = 0.002). CONCLUSIONS: The prevalence of peri-implant inflammatory disease in periodontal patients who regularly undergo SPT is clinically significant. The factors associated with peri-implant inflammatory disease were plaque index and implant location, and mucositis was also affected by the type of periodontitis the patient had.
OBJECTIVES: To describe the status of implants in periodontally compromised patients who regularly receive supportive periodontal therapy (SPT) and to determine the factors associated to peri-implant inflammatory disease in those patients. MATERIAL AND METHODS: Clinical and radiographic data of implants in periodontal patients who, after being treated and included in a SPT programme, wore implant prostheses for at least 6 months were recorded. The implants were classified according to the criteria of the 6th European Workshop on Periodontology in health, mucositis and peri-implantitis. Logistic regression analysis was performed to analyse the individual and adjusted effects of each study variable on mucositis or peri-implantitis, using SUDAAN to account for clustering (multiple implants within the patient). RESULTS: A total of 786 implants were placed in 239 patients. At patient level, 60.3%, 24.7% and 15.1% were classified as healthy, mucositis and peri-implantitispatients, respectively. At implant level, the respective percentages were 77.4%, 12.8% and 9.8%. For mucositis, at implant level, the adjusted ORs indicate a significant association with plaque index (P = 0.050), type of periodontitis (P = 0.030) and location (P = 0.045). For peri-implantitis, the adjusted ORs indicate a significant association with plaque index (P < 0.001) and location (P = 0.002). CONCLUSIONS: The prevalence of peri-implant inflammatory disease in periodontal patients who regularly undergo SPT is clinically significant. The factors associated with peri-implant inflammatory disease were plaque index and implant location, and mucositis was also affected by the type of periodontitis the patient had.
Authors: Pedro Diaz; Esther Gonzalo; Luis J Gil Villagra; Barbara Miegimolle; Maria J Suarez Journal: BMC Oral Health Date: 2022-10-19 Impact factor: 3.747